GLUE Monte Rosa Therapeutics

• None no insider bought on the open market
• $1.5M sold by 5 insiders outside a trading plan
• $2.2M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Markus Warmuth CEO
   Sale
   $220K 9,500 shares at $23.18 1.6% of stake
   Traded Jul 16 Filed Jul 17
   ↗
3. Jennifer Champoux COO
   Planned sale
   $102K 4,351 shares at $23.38 6.5% of stake
   Traded Jul 15 Filed Jul 16
   ↗
4. Sharon Townson Chief Scientific Officer
   Planned sale
   $140K 6,000 shares at $23.31 8.1% of stake
   Traded Jul 6 Filed Jul 7
   ↗
5. Filip Janku Chief Medical Officer
   Planned sale
   $132K 5,407 shares at $24.50 8.2% of stake
   Traded Jun 30 Filed Jul 1
   ↗
6. Filip Janku Chief Medical Officer
   Planned sale
   $138K 6,000 shares at $22.95 9.1% of stake
   Traded Jun 29 Filed Jun 30
   ↗
7. Anthony M. Manning Director
   Sale
   $231K 10,000 shares at $23.11 100% of stake
   Traded Jun 29 Filed Jun 30
   ↗
8. Filip Janku Chief Medical Officer
   Planned sale
   $882K 41,845 shares at $21.08 41% of stake
   Traded Jun 23–24 Filed Jun 25
   ↗
9. Sharon Townson Chief Scientific Officer
   Planned sale
   $60K 3,000 shares at $20.00 4.2% of stake
   Traded Jun 23 Filed Jun 25
   ↗
10. Jennifer Champoux COO
    Planned sale
    $44K 2,175 shares at $20.00 3.4% of stake
    Traded Jun 23 Filed Jun 25
    ↗
11. Jennifer Champoux COO
    Planned sale
    $41K 2,176 shares at $19.00 3.4% of stake
    Traded Jun 17 Filed Jun 18
    ↗
12. Sharon Townson Chief Scientific Officer
    Planned sale
    $57K 3,000 shares at $19.00 4.2% of stake
    Traded Jun 17 Filed Jun 18
    ↗
13. Markus Warmuth CEO
    Planned sale
    $106K 5,466 shares at $19.44 0.9% of stake
    Traded Jun 1 Filed Jun 2
    ↗
14. Sharon Townson Chief Scientific Officer
    Planned sale
    $119K 6,000 shares at $19.87 8.1% of stake
    Traded May 29 Filed Jun 1
    ↗
15. Jennifer Champoux COO
    Planned sale
    $44K 2,175 shares at $20.00 3.4% of stake
    Traded May 27 Filed May 28
    ↗
16. Jennifer Champoux COO
    Planned sale
    $41K 2,176 shares at $19.00 3.4% of stake
    Traded May 22 Filed May 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 8 sales to cover taxes, 6 stock grants, and 3 other transactions.